• brand
  • brand
  • brand
Sorry - Noopept 10mg by Innovagen is no longer available.

Products you may be interested

Innovagen Noopept

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

  • Innovagen Noopept
  • Innovagen Noopept
  • Innovagen Noopept

Noopept 10mg by Innovagen

Manufacturer: Innovagen

Substance: N-phenylacetyl-L-prolylglycine ethyl ester

Pack: 10mg/90tabs


Innovagen Noopept – is a drug that has a significant nootropic, antioxidant and neuroprotective effect. Noopept improves the learning ability, improves memory and at the same time exerting its influence on all phases of the process: the processing, consolidation and retrieval of information. The drug prevents the development of anemia caused by electric shocks, lack of paradoxical sleep phase, as well as the blockade of glutamatergic and central cholinergic receptor structures.

The neuroprotective effect of the Noopept drug is realized due to increasing of tissues resistance to hypoxia, toxic and traumatic injuries. In thrombotic stroke model Noopept reduces the sizes of the lesion focus, and also prevents cell death of cerebellum and cerebral cortex, which are exposed to neurotoxic doses of glutamate and free radical oxygen. Moreover, noopept reduces the effect of the excess calcium action, helps to normalize blood rheology (due to fibrinolytic, and anticoagulant and antiagregatine action).

The mechanism of nootropic action of the drug is based on its ability to form cycloprolylglycine which has a similar structure as antiamnestic endogenous cyclic dipeptide.

Innovagen Noopept increases the amplitude of transcallosal response, facilitates associative links at the level of cortical structures between the hemispheres of the brain.

During the course of the drug Noopept the restoration of cognitive functions that are decreased as a result of traumatic brain injury, prenatal damage, as well as local and global ischemia are noted.

In patients with organic lesions of the central nervous system, the effect of Noopept becomes visible on the 5th -7th day of treatment. At the beginning of therapy anxiolytic and some stimulating effects of Innovagen Noopept are admitted, and patients feel a decrease of anxiety and sleep improvement. After 2-3 weeks after the beginning of therapy a significant improvement in cognitive function is indicated.

Noopept also exerts normalizing action on vegetative system (reduces headache, tachycardia and orthostatic disorders).

The Noopept drug has no typical teratogenic, immunotoxic and mutagenic effects. Noopept does not cause addiction. After discontinuation of therapy patients do not suffer from the withdrawal syndrome.

After oral administration noopept is absorbed in the digestive tract. Bioavailability of Noopept reaches 99.7%. The active ingredient penetrates the blood-brain barrier, while its concentration in synovial fluid exceeds plasma concentrations.

Peak of plasma concentration is reached within 15 minutes after oral administration. Noopept is partially metabolized with formation of phenylacetyl- proline, cycloprolylglycine and phenylacetic acid. The half-life of Innovagen Noopept is 0.38 hours.

Noopept does not accumulate in the body.

Indications for use:

Noopept is used for the treatment of patients of different age groups (adult and elderly patients) suffering from problems with cognitive functions and emotional lability of various origins. In particular, noopept may be used after head injuries and coma, as well as in patients with inadequate cerebral circulation (including various etiologies of encephalopathy) and asthenic disorders.

Innovagen Noopept may be prescribed to improve cognitive functions (memory, concentration and learning ability) in patients with increased physical, intellectual and emotional stress.

How to use:

Noopept is manufactured for oral administration. It recommended taking tablets after meals, drinking plenty of water or unsweetened tea. To prevent the development of insomnia noopept should be taken no later than 18:00. Duration of therapy and noopept dosage should be determined by the physician.

At the beginning of therapy, the recommended dosage constitutes 10 mg twice a day. If the therapeutic effect is insufficient and patient feels no bad side effects, dose may be increased to 10 mg three times a day.

The average duration of Innovagen Noopept therapy is 1.5-3 months. If it is necessary, the second course may be carried out 1 month later after the end of the previous one. During prolonged use of Noopept high doses patient should be under medical supervision. 

Side effects:

Patients usually have no problems while taking Noopept. There are some reports about individual cases of allergic reactions. In some cases in patients with a severe form hypertension, high blood pressure may develop during administration of Noopept. At any signs of side effcts, including those that are not described in the instruction, you should immediately seek for medical help. 


Noopept should not be used by patients with hypersensitivity reactions to Noopept or to additional components of the drug. Noopept pills are not recommended for use by patients suffering from a rare form of congenital lactose intolerance. Innovagen Noopept is not used for the treatment of patients with severe forms of renal and liver dysfunctions. Noopept pills are not used in pediatric practice. 

Customer Reviews

Write Your Own Review

Only registered users can write reviews. Please, log in or register

Product Tags

Use spaces to separate tags. Use single quotes (') for phrases.